Innovacell Secures Approximately 400 Million Yen from Reos Capital Works for Innovative Cell Therapy Innovacell, a company focused on cell therapy for incontinence treatments, has successfully raised around 400 million yen through Reos Capital Works' fund.

Innovacell Secures Approximately 400 Million Yen from Reos Capital Works for Innovative Cell Therapy #Japan #Tokyo #Innovacell #Reos_Capital #ICEF15